research

Could a reduction in the cost-effectiveness threshold stymie medical research and development?

In previous posts (here and here) the comprehensive work undertaken by Claxton et al on the returns to medical expenditure in the NHS was discussed. Claxton and colleagues estimated the average change in quality adjusted… Read More »Could a reduction in the cost-effectiveness threshold stymie medical research and development?